Keyphrases
Advanced Prostate Cancer
20%
Androgen Signaling
40%
Angiogenesis
20%
Anoikis
20%
Apoptosis
20%
Castration-resistant
40%
Castration-resistant Prostate Cancer
100%
Cell Survival
20%
Chemotherapy Resistance
20%
Drug Development
20%
Drug-resistant Tumor
40%
Emerging Therapeutics
100%
Epithelial-mesenchymal Transition
100%
Metastatic Disease
20%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
20%
Multiple Signaling Pathways
20%
Novel Agents
20%
Novel Therapeutics
20%
Ongoing Clinical Trials
20%
Prostate Carcinoma
20%
Resistant Disease
20%
Signaling Axis
40%
Therapeutic Modalities
20%
Therapeutic Targeting
100%
Tumor
100%
Tumor Cells
40%
Medicine and Dentistry
Androgen
20%
Androgen Receptor
20%
Angiogenesis
20%
Anoikis
20%
Castration Resistant Prostate Cancer
100%
Cell Survival
20%
Clinical Trial
20%
Disease
20%
Mesenchymal-Epithelial Transition
100%
Metastatic Carcinoma
20%
Neoplasm
100%
Programmed Cell Death
20%
Prostate Cancer
40%
Prostate Carcinoma
20%
Signal Transduction
20%
Therapeutic Modality
20%
Tumor Cell
40%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
33%
Androgen Receptor
33%
Castration Resistant Prostate Cancer
100%
Clinical Trial
33%
Disease
33%
Drug Development
33%
Epithelium Tumor
100%
Metastasis
33%
Neoplasm
66%
Prostate Cancer
66%
Prostate Carcinoma
33%